Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-07

AUTHORS

Daniel J. Ellenberger, Dave A. Miller, Sandra U. Kucera, Robert O. Williams

ABSTRACT

Vemurafenib is a poorly soluble, low permeability drug that has a demonstrated need for a solubility-enhanced formulation. However, conventional approaches for amorphous solid dispersion production are challenging due to the physiochemical properties of the compound. A suitable and novel method for creating an amorphous solid dispersion, known as solvent-controlled coprecipitation, was developed to make a material known as microprecipitated bulk powder (MBP). However, this approach has limitations in its processing and formulation space. In this study, it was hypothesized that vemurafenib can be processed by KinetiSol into the same amorphous formulation as MBP. The KinetiSol process utilizes high shear to rapidly process amorphous solid dispersions containing vemurafenib. Analysis of the material demonstrated that KinetiSol produced amorphous, single-phase material with acceptable chemical purity and stability. Values obtained were congruent to analysis conducted on the comparator material. However, the materials differed in particle morphology as the KinetiSol material was dense, smooth, and uniform while the MBP comparator was porous in structure and exhibited high surface area. The particles produced by KinetiSol had improved in-vitro dissolution and pharmacokinetic performance for vemurafenib compared to MBP due to slower drug nucleation and recrystallization which resulted in superior supersaturation maintenance during drug release. In the in-vivo rat pharmacokinetic study, both amorphous solid dispersions produced by KinetiSol exhibited mean AUC values at least two-fold that of MBP when dosed as a suspension. It was concluded that the KinetiSol process produced superior dosage forms containing vemurafenib with the potential for substantial reduction in patient pill burden. More... »

PAGES

1957-1970

References to SciGraph publications

  • 2016. Melt Extrusion in FORMULATING POORLY WATER SOLUBLE DRUGS
  • 2016-02. Thermal Processing of PVP- and HPMC-Based Amorphous Solid Dispersions in AAPS PHARMSCITECH
  • 2012-08. Drug Absorption Interactions Between Oral Targeted Anticancer Agents and PPIs: Is pH‐Dependent Solubility the Achilles Heel of Targeted Therapy? in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 1995-06. Molecular Mobility of Amorphous Pharmaceutical Solids Below Their Glass Transition Temperatures in PHARMACEUTICAL RESEARCH
  • 2010-08. Phospholipids and Lipid-Based Formulations in Oral Drug Delivery in PHARMACEUTICAL RESEARCH
  • 1995-03. A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability in PHARMACEUTICAL RESEARCH
  • 2009-12. Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World’s Top Oral Drugs in THE AAPS JOURNAL
  • 2016-02. Challenges and Strategies in Thermal Processing of Amorphous Solid Dispersions: A Review in AAPS PHARMSCITECH
  • 2014. Hot-Melt Extrusion for Solid Dispersions: Composition and Design Considerations in AMORPHOUS SOLID DISPERSIONS
  • 2002-09. Improvement of Dissolution Rates of Poorly Water Soluble APIs Using Novel Spray Freezing into Liquid Technology in PHARMACEUTICAL RESEARCH
  • 2009-06. Utility of Hydroxypropylmethylcellulose Acetate Succinate (HPMCAS) for Initiation and Maintenance of Drug Supersaturation in the GI Milieu in PHARMACEUTICAL RESEARCH
  • 2012-11. Vemurafenib: the first drug approved for BRAF-mutant cancer in NATURE REVIEWS DRUG DISCOVERY
  • 2011-11. Vemurafenib in NATURE REVIEWS DRUG DISCOVERY
  • 2010-06. Dissolution Enhancement of a Drug Exhibiting Thermal and Acidic Decomposition Characteristics by Fusion Processing: A Comparative Study of Hot Melt Extrusion and KinetiSol® Dispersing in AAPS PHARMSCITECH
  • 2018-07. Effects of the Preparation Process on the Properties of Amorphous Solid Dispersions in AAPS PHARMSCITECH
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1

    DOI

    http://dx.doi.org/10.1208/s12249-018-0988-1

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1101528674

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29541940


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0306", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Physical Chemistry (incl. Structural)", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/03", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Chemical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Agents", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Calorimetry, Differential Scanning", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Chemistry, Pharmaceutical", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Crystallization", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Desiccation", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dosage Forms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Compounding", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Stability", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Indoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Particle Size", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Powders", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats, Sprague-Dawley", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Solubility", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Sulfonamides", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Vemurafenib", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "X-Ray Diffraction", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "The University of Texas at Austin", 
              "id": "https://www.grid.ac/institutes/grid.89336.37", 
              "name": [
                "DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA", 
                "College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, 78712, Austin, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ellenberger", 
            "givenName": "Daniel J.", 
            "id": "sg:person.0600654057.17", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600654057.17"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Miller", 
            "givenName": "Dave A.", 
            "id": "sg:person.0700304357.60", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700304357.60"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "name": [
                "DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kucera", 
            "givenName": "Sandra U.", 
            "id": "sg:person.0601407165.07", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601407165.07"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "The University of Texas at Austin", 
              "id": "https://www.grid.ac/institutes/grid.89336.37", 
              "name": [
                "College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, 78712, Austin, Texas, USA"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Williams", 
            "givenName": "Robert O.", 
            "id": "sg:person.01211140532.32", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211140532.32"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "https://doi.org/10.1016/j.ejpb.2007.11.004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000069156"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.3109/03639045.2014.971027", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000190499"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2013.05.061", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000453340"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/s12249-015-0417-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000672990", 
              "https://doi.org/10.1208/s12249-015-0417-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmoa1408868", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000859328"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-009-9852-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001516558", 
              "https://doi.org/10.1007/s11095-009-9852-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-009-9852-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001516558", 
              "https://doi.org/10.1007/s11095-009-9852-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.23425", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002093860"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/prp2.113", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002214116"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd3847", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004232546", 
              "https://doi.org/10.1038/nrd3847"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2007.12.017", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006661742"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ejpb.2009.09.007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007013343"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0378-5173(83)90064-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007844718"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0378-5173(83)90064-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1007844718"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ddtec.2011.10.002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009081965"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ddtec.2011.10.002", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1009081965"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.carbpol.2013.09.017", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010117913"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0939-6411(00)00076-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010715816"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0939-6411(96)00037-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010784506"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-010-0130-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012311683", 
              "https://doi.org/10.1007/s11095-010-0130-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11095-010-0130-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012311683", 
              "https://doi.org/10.1007/s11095-010-0130-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1056/nejmc1302338", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012716185"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ejpb.2013.09.007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1013760714"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/acschembio.5b00174", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015977540"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.2600540202", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1016640642"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2006.07.011", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019673284"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2012.08.031", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1021424172"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0040517512468815", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022221523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1177/0040517512468815", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022221523"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nrd3579", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022770880", 
              "https://doi.org/10.1038/nrd3579"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/ijc.28168", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025164898"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2011.08.007", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027073494"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.22074", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027233167"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.2600831211", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031087388"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.2012.73", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1031895836", 
              "https://doi.org/10.1038/clpt.2012.73"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/s0378-5173(98)00400-1", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1033324116"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.24541", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1036349671"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1016212804288", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037126380", 
              "https://doi.org/10.1023/a:1016212804288"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1020390422785", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037263988", 
              "https://doi.org/10.1023/a:1020390422785"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-319-42609-9_9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037380114", 
              "https://doi.org/10.1007/978-3-319-42609-9_9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1021/js980403l", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037849804"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.21650", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038163237"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/anie.200806299", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038857996"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/anie.200806299", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038857996"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2012.08.032", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1040358693"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.addr.2016.02.005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041048322"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.addr.2016.02.005", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041048322"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/s12248-009-9144-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043278894", 
              "https://doi.org/10.1208/s12248-009-9144-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/s12249-010-9431-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046529857", 
              "https://doi.org/10.1208/s12249-010-9431-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-1-4939-1598-9_6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1046538574", 
              "https://doi.org/10.1007/978-1-4939-1598-9_6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/0378-5173(95)00033-f", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047257017"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.apsb.2013.10.001", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051406957"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/s12249-015-0393-y", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051714926", 
              "https://doi.org/10.1208/s12249-015-0393-y"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1002/jps.21367", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052662120"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1023/a:1016292416526", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052847671", 
              "https://doi.org/10.1023/a:1016292416526"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1016/j.ijpharm.2012.07.015", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1053536579"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/01926230701226575", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1058308389"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1080/01926230701226575", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1058308389"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1208/s12249-017-0861-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091836467", 
              "https://doi.org/10.1208/s12249-017-0861-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "https://doi.org/10.1200/jco.2014.32.15_suppl.3516", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1111106124"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-07", 
        "datePublishedReg": "2018-07-01", 
        "description": "Vemurafenib is a poorly soluble, low permeability drug that has a demonstrated need for a solubility-enhanced formulation. However, conventional approaches for amorphous solid dispersion production are challenging due to the physiochemical properties of the compound. A suitable and novel method for creating an amorphous solid dispersion, known as solvent-controlled coprecipitation, was developed to make a material known as microprecipitated bulk powder (MBP). However, this approach has limitations in its processing and formulation space. In this study, it was hypothesized that vemurafenib can be processed by KinetiSol into the same amorphous formulation as MBP. The KinetiSol process utilizes high shear to rapidly process amorphous solid dispersions containing vemurafenib. Analysis of the material demonstrated that KinetiSol produced amorphous, single-phase material with acceptable chemical purity and stability. Values obtained were congruent to analysis conducted on the comparator material. However, the materials differed in particle morphology as the KinetiSol material was dense, smooth, and uniform while the MBP comparator was porous in structure and exhibited high surface area. The particles produced by KinetiSol had improved in-vitro dissolution and pharmacokinetic performance for vemurafenib compared to MBP due to slower drug nucleation and recrystallization which resulted in superior supersaturation maintenance during drug release. In the in-vivo rat pharmacokinetic study, both amorphous solid dispersions produced by KinetiSol exhibited mean AUC values at least two-fold that of MBP when dosed as a suspension. It was concluded that the KinetiSol process produced superior dosage forms containing vemurafenib with the potential for substantial reduction in patient pill burden.", 
        "genre": "research_article", 
        "id": "sg:pub.10.1208/s12249-018-0988-1", 
        "inLanguage": [
          "en"
        ], 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1023420", 
            "issn": [
              "1530-9932"
            ], 
            "name": "AAPS PharmSciTech", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "19"
          }
        ], 
        "name": "Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol\u00ae Processing", 
        "pagination": "1957-1970", 
        "productId": [
          {
            "name": "readcube_id", 
            "type": "PropertyValue", 
            "value": [
              "08b92c287ea6bf1d1c4a39cc69e7add0a380f25da395fdbfe2ccbf58c4861898"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29541940"
            ]
          }, 
          {
            "name": "nlm_unique_id", 
            "type": "PropertyValue", 
            "value": [
              "100960111"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1208/s12249-018-0988-1"
            ]
          }, 
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1101528674"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1208/s12249-018-0988-1", 
          "https://app.dimensions.ai/details/publication/pub.1101528674"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2019-04-11T12:15", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000361_0000000361/records_54011_00000001.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://link.springer.com/10.1208%2Fs12249-018-0988-1"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1208/s12249-018-0988-1'


     

    This table displays all metadata directly associated to this object as RDF triples.

    341 TRIPLES      21 PREDICATES      100 URIs      40 LITERALS      28 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1208/s12249-018-0988-1 schema:about N0b75a1516dca4ec3a11b978340de24ed
    2 N1adcd2edb28e4f838c1ef29385e27174
    3 N1ebd499c19fa42659a1824cefa9ecee5
    4 N3965a5c860704027a209c93f56c1fbe5
    5 N48f148e878264e96af3ae89659100a56
    6 N62e1a916f6ec4741a1a8dcb458786be0
    7 N6c1e53e812bd4e1b820d2f358b74c160
    8 N7f96a5d1c4754218a4ae0e80d968301e
    9 N8361ba6578bf4157bcd3512e0372f439
    10 N8ca287a14e3f4a0ea9a3b715a79589ce
    11 N9bcf60f98e0744c0a12bf086bc54abec
    12 N9e9fbaf0d5cc42f7bf56a7c838f5665e
    13 Naa6a699cda0b4ab49c1b7219b6586f18
    14 Naceef35af2974b1aa93c891f0a743496
    15 Nb11a27216c5f43bc875af3c474eabc80
    16 Nb8e52bb78d4245cd83f4b9c2937281c1
    17 Ne479c3cf340d48cea81aa30211746288
    18 Ne47fbd0e3a234885928b7aa1dfb35d37
    19 Nfc826d1a84ed433a8454832886682686
    20 anzsrc-for:03
    21 anzsrc-for:0306
    22 schema:author N5f80dd520ed946cdbdbc76ef75424f69
    23 schema:citation sg:pub.10.1007/978-1-4939-1598-9_6
    24 sg:pub.10.1007/978-3-319-42609-9_9
    25 sg:pub.10.1007/s11095-009-9852-z
    26 sg:pub.10.1007/s11095-010-0130-x
    27 sg:pub.10.1023/a:1016212804288
    28 sg:pub.10.1023/a:1016292416526
    29 sg:pub.10.1023/a:1020390422785
    30 sg:pub.10.1038/clpt.2012.73
    31 sg:pub.10.1038/nrd3579
    32 sg:pub.10.1038/nrd3847
    33 sg:pub.10.1208/s12248-009-9144-x
    34 sg:pub.10.1208/s12249-010-9431-y
    35 sg:pub.10.1208/s12249-015-0393-y
    36 sg:pub.10.1208/s12249-015-0417-7
    37 sg:pub.10.1208/s12249-017-0861-7
    38 https://doi.org/10.1002/anie.200806299
    39 https://doi.org/10.1002/ijc.28168
    40 https://doi.org/10.1002/jps.21367
    41 https://doi.org/10.1002/jps.21650
    42 https://doi.org/10.1002/jps.22074
    43 https://doi.org/10.1002/jps.23425
    44 https://doi.org/10.1002/jps.24541
    45 https://doi.org/10.1002/jps.2600540202
    46 https://doi.org/10.1002/jps.2600831211
    47 https://doi.org/10.1002/prp2.113
    48 https://doi.org/10.1016/0378-5173(83)90064-9
    49 https://doi.org/10.1016/0378-5173(95)00033-f
    50 https://doi.org/10.1016/j.addr.2016.02.005
    51 https://doi.org/10.1016/j.apsb.2013.10.001
    52 https://doi.org/10.1016/j.carbpol.2013.09.017
    53 https://doi.org/10.1016/j.ddtec.2011.10.002
    54 https://doi.org/10.1016/j.ejpb.2007.11.004
    55 https://doi.org/10.1016/j.ejpb.2009.09.007
    56 https://doi.org/10.1016/j.ejpb.2013.09.007
    57 https://doi.org/10.1016/j.ijpharm.2006.07.011
    58 https://doi.org/10.1016/j.ijpharm.2007.12.017
    59 https://doi.org/10.1016/j.ijpharm.2011.08.007
    60 https://doi.org/10.1016/j.ijpharm.2012.07.015
    61 https://doi.org/10.1016/j.ijpharm.2012.08.031
    62 https://doi.org/10.1016/j.ijpharm.2012.08.032
    63 https://doi.org/10.1016/j.ijpharm.2013.05.061
    64 https://doi.org/10.1016/s0378-5173(98)00400-1
    65 https://doi.org/10.1016/s0939-6411(00)00076-x
    66 https://doi.org/10.1016/s0939-6411(96)00037-9
    67 https://doi.org/10.1021/acschembio.5b00174
    68 https://doi.org/10.1021/js980403l
    69 https://doi.org/10.1056/nejmc1302338
    70 https://doi.org/10.1056/nejmoa1408868
    71 https://doi.org/10.1080/01926230701226575
    72 https://doi.org/10.1177/0040517512468815
    73 https://doi.org/10.1200/jco.2014.32.15_suppl.3516
    74 https://doi.org/10.3109/03639045.2014.971027
    75 schema:datePublished 2018-07
    76 schema:datePublishedReg 2018-07-01
    77 schema:description Vemurafenib is a poorly soluble, low permeability drug that has a demonstrated need for a solubility-enhanced formulation. However, conventional approaches for amorphous solid dispersion production are challenging due to the physiochemical properties of the compound. A suitable and novel method for creating an amorphous solid dispersion, known as solvent-controlled coprecipitation, was developed to make a material known as microprecipitated bulk powder (MBP). However, this approach has limitations in its processing and formulation space. In this study, it was hypothesized that vemurafenib can be processed by KinetiSol into the same amorphous formulation as MBP. The KinetiSol process utilizes high shear to rapidly process amorphous solid dispersions containing vemurafenib. Analysis of the material demonstrated that KinetiSol produced amorphous, single-phase material with acceptable chemical purity and stability. Values obtained were congruent to analysis conducted on the comparator material. However, the materials differed in particle morphology as the KinetiSol material was dense, smooth, and uniform while the MBP comparator was porous in structure and exhibited high surface area. The particles produced by KinetiSol had improved in-vitro dissolution and pharmacokinetic performance for vemurafenib compared to MBP due to slower drug nucleation and recrystallization which resulted in superior supersaturation maintenance during drug release. In the in-vivo rat pharmacokinetic study, both amorphous solid dispersions produced by KinetiSol exhibited mean AUC values at least two-fold that of MBP when dosed as a suspension. It was concluded that the KinetiSol process produced superior dosage forms containing vemurafenib with the potential for substantial reduction in patient pill burden.
    78 schema:genre research_article
    79 schema:inLanguage en
    80 schema:isAccessibleForFree false
    81 schema:isPartOf N25b1a8783e7e419f93b1d2eb272b6f4b
    82 Nc0824ff75bf347dfa47d109f122c8b48
    83 sg:journal.1023420
    84 schema:name Improved Vemurafenib Dissolution and Pharmacokinetics as an Amorphous Solid Dispersion Produced by KinetiSol® Processing
    85 schema:pagination 1957-1970
    86 schema:productId N0718d1203767423cacba516cbc9a93f1
    87 N19a0db75d783429d9cc205eccaed5cdf
    88 N579feefdd131448d8ff2a7c9edca9fee
    89 N949a863e620b4043838d94a5861db5fc
    90 Nb3a0e8e7f4d34709aeee9c78385dcbd9
    91 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101528674
    92 https://doi.org/10.1208/s12249-018-0988-1
    93 schema:sdDatePublished 2019-04-11T12:15
    94 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    95 schema:sdPublisher N7b319be44c3f42938af9c53bd12638ff
    96 schema:url https://link.springer.com/10.1208%2Fs12249-018-0988-1
    97 sgo:license sg:explorer/license/
    98 sgo:sdDataset articles
    99 rdf:type schema:ScholarlyArticle
    100 N0718d1203767423cacba516cbc9a93f1 schema:name pubmed_id
    101 schema:value 29541940
    102 rdf:type schema:PropertyValue
    103 N0b75a1516dca4ec3a11b978340de24ed schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    104 schema:name Chemistry, Pharmaceutical
    105 rdf:type schema:DefinedTerm
    106 N19a0db75d783429d9cc205eccaed5cdf schema:name nlm_unique_id
    107 schema:value 100960111
    108 rdf:type schema:PropertyValue
    109 N1adcd2edb28e4f838c1ef29385e27174 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    110 schema:name Male
    111 rdf:type schema:DefinedTerm
    112 N1ebd499c19fa42659a1824cefa9ecee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    113 schema:name Crystallization
    114 rdf:type schema:DefinedTerm
    115 N2310fea4d262430f938c2e18d3b2e055 schema:name DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA
    116 rdf:type schema:Organization
    117 N25b1a8783e7e419f93b1d2eb272b6f4b schema:issueNumber 5
    118 rdf:type schema:PublicationIssue
    119 N3965a5c860704027a209c93f56c1fbe5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    120 schema:name Particle Size
    121 rdf:type schema:DefinedTerm
    122 N48f148e878264e96af3ae89659100a56 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Rats, Sprague-Dawley
    124 rdf:type schema:DefinedTerm
    125 N579feefdd131448d8ff2a7c9edca9fee schema:name dimensions_id
    126 schema:value pub.1101528674
    127 rdf:type schema:PropertyValue
    128 N5f80dd520ed946cdbdbc76ef75424f69 rdf:first sg:person.0600654057.17
    129 rdf:rest N6cf21fdb73964929b0c7f1c20a595741
    130 N62e1a916f6ec4741a1a8dcb458786be0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    131 schema:name Dosage Forms
    132 rdf:type schema:DefinedTerm
    133 N6c1e53e812bd4e1b820d2f358b74c160 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    134 schema:name Antineoplastic Agents
    135 rdf:type schema:DefinedTerm
    136 N6cf21fdb73964929b0c7f1c20a595741 rdf:first sg:person.0700304357.60
    137 rdf:rest Ncf35325877cc4722a7fb6a674d20eeec
    138 N7ad87e5e85fa46e3947d8236ff058a04 schema:name DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA
    139 rdf:type schema:Organization
    140 N7b319be44c3f42938af9c53bd12638ff schema:name Springer Nature - SN SciGraph project
    141 rdf:type schema:Organization
    142 N7f96a5d1c4754218a4ae0e80d968301e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    143 schema:name Animals
    144 rdf:type schema:DefinedTerm
    145 N8361ba6578bf4157bcd3512e0372f439 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    146 schema:name Drug Stability
    147 rdf:type schema:DefinedTerm
    148 N89b6f22e94f44f1eab5ac62b526357dd rdf:first sg:person.01211140532.32
    149 rdf:rest rdf:nil
    150 N8ca287a14e3f4a0ea9a3b715a79589ce schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    151 schema:name Solubility
    152 rdf:type schema:DefinedTerm
    153 N949a863e620b4043838d94a5861db5fc schema:name doi
    154 schema:value 10.1208/s12249-018-0988-1
    155 rdf:type schema:PropertyValue
    156 N9bcf60f98e0744c0a12bf086bc54abec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Rats
    158 rdf:type schema:DefinedTerm
    159 N9e9fbaf0d5cc42f7bf56a7c838f5665e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Vemurafenib
    161 rdf:type schema:DefinedTerm
    162 Naa6a699cda0b4ab49c1b7219b6586f18 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Sulfonamides
    164 rdf:type schema:DefinedTerm
    165 Naceef35af2974b1aa93c891f0a743496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Powders
    167 rdf:type schema:DefinedTerm
    168 Nb11a27216c5f43bc875af3c474eabc80 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name X-Ray Diffraction
    170 rdf:type schema:DefinedTerm
    171 Nb3a0e8e7f4d34709aeee9c78385dcbd9 schema:name readcube_id
    172 schema:value 08b92c287ea6bf1d1c4a39cc69e7add0a380f25da395fdbfe2ccbf58c4861898
    173 rdf:type schema:PropertyValue
    174 Nb8e52bb78d4245cd83f4b9c2937281c1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    175 schema:name Calorimetry, Differential Scanning
    176 rdf:type schema:DefinedTerm
    177 Nc0824ff75bf347dfa47d109f122c8b48 schema:volumeNumber 19
    178 rdf:type schema:PublicationVolume
    179 Ncf35325877cc4722a7fb6a674d20eeec rdf:first sg:person.0601407165.07
    180 rdf:rest N89b6f22e94f44f1eab5ac62b526357dd
    181 Ne479c3cf340d48cea81aa30211746288 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    182 schema:name Drug Compounding
    183 rdf:type schema:DefinedTerm
    184 Ne47fbd0e3a234885928b7aa1dfb35d37 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    185 schema:name Indoles
    186 rdf:type schema:DefinedTerm
    187 Nfc826d1a84ed433a8454832886682686 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    188 schema:name Desiccation
    189 rdf:type schema:DefinedTerm
    190 anzsrc-for:03 schema:inDefinedTermSet anzsrc-for:
    191 schema:name Chemical Sciences
    192 rdf:type schema:DefinedTerm
    193 anzsrc-for:0306 schema:inDefinedTermSet anzsrc-for:
    194 schema:name Physical Chemistry (incl. Structural)
    195 rdf:type schema:DefinedTerm
    196 sg:journal.1023420 schema:issn 1530-9932
    197 schema:name AAPS PharmSciTech
    198 rdf:type schema:Periodical
    199 sg:person.01211140532.32 schema:affiliation https://www.grid.ac/institutes/grid.89336.37
    200 schema:familyName Williams
    201 schema:givenName Robert O.
    202 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01211140532.32
    203 rdf:type schema:Person
    204 sg:person.0600654057.17 schema:affiliation https://www.grid.ac/institutes/grid.89336.37
    205 schema:familyName Ellenberger
    206 schema:givenName Daniel J.
    207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0600654057.17
    208 rdf:type schema:Person
    209 sg:person.0601407165.07 schema:affiliation N7ad87e5e85fa46e3947d8236ff058a04
    210 schema:familyName Kucera
    211 schema:givenName Sandra U.
    212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0601407165.07
    213 rdf:type schema:Person
    214 sg:person.0700304357.60 schema:affiliation N2310fea4d262430f938c2e18d3b2e055
    215 schema:familyName Miller
    216 schema:givenName Dave A.
    217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0700304357.60
    218 rdf:type schema:Person
    219 sg:pub.10.1007/978-1-4939-1598-9_6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046538574
    220 https://doi.org/10.1007/978-1-4939-1598-9_6
    221 rdf:type schema:CreativeWork
    222 sg:pub.10.1007/978-3-319-42609-9_9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037380114
    223 https://doi.org/10.1007/978-3-319-42609-9_9
    224 rdf:type schema:CreativeWork
    225 sg:pub.10.1007/s11095-009-9852-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1001516558
    226 https://doi.org/10.1007/s11095-009-9852-z
    227 rdf:type schema:CreativeWork
    228 sg:pub.10.1007/s11095-010-0130-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012311683
    229 https://doi.org/10.1007/s11095-010-0130-x
    230 rdf:type schema:CreativeWork
    231 sg:pub.10.1023/a:1016212804288 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037126380
    232 https://doi.org/10.1023/a:1016212804288
    233 rdf:type schema:CreativeWork
    234 sg:pub.10.1023/a:1016292416526 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052847671
    235 https://doi.org/10.1023/a:1016292416526
    236 rdf:type schema:CreativeWork
    237 sg:pub.10.1023/a:1020390422785 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037263988
    238 https://doi.org/10.1023/a:1020390422785
    239 rdf:type schema:CreativeWork
    240 sg:pub.10.1038/clpt.2012.73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031895836
    241 https://doi.org/10.1038/clpt.2012.73
    242 rdf:type schema:CreativeWork
    243 sg:pub.10.1038/nrd3579 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022770880
    244 https://doi.org/10.1038/nrd3579
    245 rdf:type schema:CreativeWork
    246 sg:pub.10.1038/nrd3847 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004232546
    247 https://doi.org/10.1038/nrd3847
    248 rdf:type schema:CreativeWork
    249 sg:pub.10.1208/s12248-009-9144-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1043278894
    250 https://doi.org/10.1208/s12248-009-9144-x
    251 rdf:type schema:CreativeWork
    252 sg:pub.10.1208/s12249-010-9431-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046529857
    253 https://doi.org/10.1208/s12249-010-9431-y
    254 rdf:type schema:CreativeWork
    255 sg:pub.10.1208/s12249-015-0393-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1051714926
    256 https://doi.org/10.1208/s12249-015-0393-y
    257 rdf:type schema:CreativeWork
    258 sg:pub.10.1208/s12249-015-0417-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000672990
    259 https://doi.org/10.1208/s12249-015-0417-7
    260 rdf:type schema:CreativeWork
    261 sg:pub.10.1208/s12249-017-0861-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091836467
    262 https://doi.org/10.1208/s12249-017-0861-7
    263 rdf:type schema:CreativeWork
    264 https://doi.org/10.1002/anie.200806299 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038857996
    265 rdf:type schema:CreativeWork
    266 https://doi.org/10.1002/ijc.28168 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025164898
    267 rdf:type schema:CreativeWork
    268 https://doi.org/10.1002/jps.21367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052662120
    269 rdf:type schema:CreativeWork
    270 https://doi.org/10.1002/jps.21650 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038163237
    271 rdf:type schema:CreativeWork
    272 https://doi.org/10.1002/jps.22074 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027233167
    273 rdf:type schema:CreativeWork
    274 https://doi.org/10.1002/jps.23425 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002093860
    275 rdf:type schema:CreativeWork
    276 https://doi.org/10.1002/jps.24541 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036349671
    277 rdf:type schema:CreativeWork
    278 https://doi.org/10.1002/jps.2600540202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016640642
    279 rdf:type schema:CreativeWork
    280 https://doi.org/10.1002/jps.2600831211 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031087388
    281 rdf:type schema:CreativeWork
    282 https://doi.org/10.1002/prp2.113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002214116
    283 rdf:type schema:CreativeWork
    284 https://doi.org/10.1016/0378-5173(83)90064-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007844718
    285 rdf:type schema:CreativeWork
    286 https://doi.org/10.1016/0378-5173(95)00033-f schema:sameAs https://app.dimensions.ai/details/publication/pub.1047257017
    287 rdf:type schema:CreativeWork
    288 https://doi.org/10.1016/j.addr.2016.02.005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041048322
    289 rdf:type schema:CreativeWork
    290 https://doi.org/10.1016/j.apsb.2013.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051406957
    291 rdf:type schema:CreativeWork
    292 https://doi.org/10.1016/j.carbpol.2013.09.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010117913
    293 rdf:type schema:CreativeWork
    294 https://doi.org/10.1016/j.ddtec.2011.10.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009081965
    295 rdf:type schema:CreativeWork
    296 https://doi.org/10.1016/j.ejpb.2007.11.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000069156
    297 rdf:type schema:CreativeWork
    298 https://doi.org/10.1016/j.ejpb.2009.09.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007013343
    299 rdf:type schema:CreativeWork
    300 https://doi.org/10.1016/j.ejpb.2013.09.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013760714
    301 rdf:type schema:CreativeWork
    302 https://doi.org/10.1016/j.ijpharm.2006.07.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019673284
    303 rdf:type schema:CreativeWork
    304 https://doi.org/10.1016/j.ijpharm.2007.12.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006661742
    305 rdf:type schema:CreativeWork
    306 https://doi.org/10.1016/j.ijpharm.2011.08.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027073494
    307 rdf:type schema:CreativeWork
    308 https://doi.org/10.1016/j.ijpharm.2012.07.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053536579
    309 rdf:type schema:CreativeWork
    310 https://doi.org/10.1016/j.ijpharm.2012.08.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021424172
    311 rdf:type schema:CreativeWork
    312 https://doi.org/10.1016/j.ijpharm.2012.08.032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040358693
    313 rdf:type schema:CreativeWork
    314 https://doi.org/10.1016/j.ijpharm.2013.05.061 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000453340
    315 rdf:type schema:CreativeWork
    316 https://doi.org/10.1016/s0378-5173(98)00400-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033324116
    317 rdf:type schema:CreativeWork
    318 https://doi.org/10.1016/s0939-6411(00)00076-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010715816
    319 rdf:type schema:CreativeWork
    320 https://doi.org/10.1016/s0939-6411(96)00037-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010784506
    321 rdf:type schema:CreativeWork
    322 https://doi.org/10.1021/acschembio.5b00174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015977540
    323 rdf:type schema:CreativeWork
    324 https://doi.org/10.1021/js980403l schema:sameAs https://app.dimensions.ai/details/publication/pub.1037849804
    325 rdf:type schema:CreativeWork
    326 https://doi.org/10.1056/nejmc1302338 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012716185
    327 rdf:type schema:CreativeWork
    328 https://doi.org/10.1056/nejmoa1408868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000859328
    329 rdf:type schema:CreativeWork
    330 https://doi.org/10.1080/01926230701226575 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058308389
    331 rdf:type schema:CreativeWork
    332 https://doi.org/10.1177/0040517512468815 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022221523
    333 rdf:type schema:CreativeWork
    334 https://doi.org/10.1200/jco.2014.32.15_suppl.3516 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111106124
    335 rdf:type schema:CreativeWork
    336 https://doi.org/10.3109/03639045.2014.971027 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000190499
    337 rdf:type schema:CreativeWork
    338 https://www.grid.ac/institutes/grid.89336.37 schema:alternateName The University of Texas at Austin
    339 schema:name College of Pharmacy, The University of Texas at Austin, 1 University Station, Campus Mail Code A1902, 78712, Austin, Texas, USA
    340 DisperSol Technologies, LLC, 111 W. Cooperative Way, Building 2, Suite 200, 78626, Georgetown, Texas, USA
    341 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...